Dobutamine administration in septic shock: Addition to a standard protocol
Dobutamine administration has been shown to increase oxygen delivery in various conditions, but there are little,data to document its effects in septic shock. We investigated the effects of dobutamine infusion at a rate of 5 μg/kg· min in 18 patients (mean 60 ± 16 yr) with septic shock initially cha...
Gespeichert in:
| Veröffentlicht in: | Critical care medicine 1990-07, Vol.18 (7), p.689-693 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 693 |
|---|---|
| container_issue | 7 |
| container_start_page | 689 |
| container_title | Critical care medicine |
| container_volume | 18 |
| creator | VINCENT, JEAN-LOUIS ROMAL, ALAIN KHN, ROBERT J |
| description | Dobutamine administration has been shown to increase oxygen delivery in various conditions, but there are little,data to document its effects in septic shock. We investigated the effects of dobutamine infusion at a rate of 5 μg/kg· min in 18 patients (mean 60 ± 16 yr) with septic shock initially characterized by hypotension, oliguria, and hyperlactatemia in the presence of a documented source of sepsis. Early resuscitation had consisted of fluid administration and vasopressors when required. When added to this standard regimen, dobutamine had no significant effect on mean arterial pressure (MAP) (from 71 ± 12 to 73 ± 13 mm Hg), but markedly increased cardiac index (from 3.0 ± 0.7 to 3.9 ± 1.0 L/min· m, p |
| doi_str_mv | 10.1097/00003246-199007000-00001 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79851810</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79851810</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4561-f4dcb54d186c3ab693925857707f6632a5bc3e8bd55057f883581e8955f8dcdc3</originalsourceid><addsrcrecordid>eNqFkctOGzEUhq2KKoS0j1DJG9gN2ON7dwgKpYrUTbu2PLZHMUzGwfYo6tvXuZCuUL05Ouf_z0WfAYAYXWOkxA2qj7SUN1gphETNml0JfwBzzEhNWkXOwBwhhRpCFTkHFzk_VwNlgszArCWcCiTn4Md97KZi1mH00LgaQi7JlBBHGEaY_aYEC_Mq2pev8Na5sFdKhAbmYkZnkoObFEu0cfgEPvZmyP7zMS7A74dvv-6-N8ufj093t8vGUsZx01NnO0YdltwS03FFVMskEwKJnnPSGtZZ4mXnGENM9FISJrGXirFeOussWYCrw9y6-HXyueh1yNYPgxl9nLIWSjIsMfqvEfOKjgpSjfJgtCnmnHyvNymsTfqjMdI73vqNtz7x3pdwbf1y3DF1a-9OjUfAVb886iZbM_TJjDbkf_MVkRTz3Qn04NvGofiUX4Zp65NeeTOUlX7vu8lfCS6WbA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16007473</pqid></control><display><type>article</type><title>Dobutamine administration in septic shock: Addition to a standard protocol</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>VINCENT, JEAN-LOUIS ; ROMAL, ALAIN ; KHN, ROBERT J</creator><creatorcontrib>VINCENT, JEAN-LOUIS ; ROMAL, ALAIN ; KHN, ROBERT J</creatorcontrib><description><![CDATA[Dobutamine administration has been shown to increase oxygen delivery in various conditions, but there are little,data to document its effects in septic shock. We investigated the effects of dobutamine infusion at a rate of 5 μg/kg· min in 18 patients (mean 60 ± 16 yr) with septic shock initially characterized by hypotension, oliguria, and hyperlactatemia in the presence of a documented source of sepsis. Early resuscitation had consisted of fluid administration and vasopressors when required. When added to this standard regimen, dobutamine had no significant effect on mean arterial pressure (MAP) (from 71 ± 12 to 73 ± 13 mm Hg), but markedly increased cardiac index (from 3.0 ± 0.7 to 3.9 ± 1.0 L/min· m, p<.001), stroke index (from 32 ± 8 to 37 ± 9 ml/m, p<.001) and oxygen transport (from 410 ± 105 to 530 ± 146 ml/min· m, p<.002). Oxygen consumption (VO2) increased concurrently (from 137 ± 42 to 162 ± 66 ml/min·.m2, p<.002). MAP increased (from 68 ± 9 to 76 ± 11 mm Hg) in 12 patients and decreased moderately (from 76 ± 18 to 69 ± 17 mm Hg) in six patients. The two subgroups of patients had similar hemodynamic profiles before the dobutamine infusion, but vasopressor therapy was already used in one of the 12 patients in the first subgroup and in three of the six patients in the second subgroup (p<.05). Tne BP decrease in the second subgroup was related to a vascular effect associated with a larger decrease in systemic vascular resistance (−24% vs. −10% in the other patients). A significant decrease in right atrial pressare (from 13.0 ± 4.2 to 10.0 ± 3.8 mm Hg, p<.01) also suggested a decrease in preload, Hence, dobutamine infusion at a dose of 5 μg/kg· min can markedly increase oxgyen supply and VO2 in septic shock, and is well tolerated. (Grit Care Med 1990; 18:689)]]></description><identifier>ISSN: 0090-3493</identifier><identifier>EISSN: 1530-0293</identifier><identifier>DOI: 10.1097/00003246-199007000-00001</identifier><identifier>PMID: 2364708</identifier><identifier>CODEN: CCMDC7</identifier><language>eng</language><publisher>Hagerstown, MD: Williams & Wilkins</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Cardiotonic agents ; Cardiovascular system ; Dobutamine - administration & dosage ; Dobutamine - therapeutic use ; Drug Evaluation ; Female ; Hemodynamics - drug effects ; Humans ; Infusions, Intravenous ; Lactates - blood ; Male ; Medical sciences ; Middle Aged ; Oxygen Consumption ; Pharmacology. Drug treatments ; Prospective Studies ; Respiration, Artificial ; Shock, Septic - drug therapy ; Shock, Septic - physiopathology</subject><ispartof>Critical care medicine, 1990-07, Vol.18 (7), p.689-693</ispartof><rights>Williams & Wilkins 1990. All Rights Reserved.</rights><rights>1991 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19384163$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2364708$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VINCENT, JEAN-LOUIS</creatorcontrib><creatorcontrib>ROMAL, ALAIN</creatorcontrib><creatorcontrib>KHN, ROBERT J</creatorcontrib><title>Dobutamine administration in septic shock: Addition to a standard protocol</title><title>Critical care medicine</title><addtitle>Crit Care Med</addtitle><description><![CDATA[Dobutamine administration has been shown to increase oxygen delivery in various conditions, but there are little,data to document its effects in septic shock. We investigated the effects of dobutamine infusion at a rate of 5 μg/kg· min in 18 patients (mean 60 ± 16 yr) with septic shock initially characterized by hypotension, oliguria, and hyperlactatemia in the presence of a documented source of sepsis. Early resuscitation had consisted of fluid administration and vasopressors when required. When added to this standard regimen, dobutamine had no significant effect on mean arterial pressure (MAP) (from 71 ± 12 to 73 ± 13 mm Hg), but markedly increased cardiac index (from 3.0 ± 0.7 to 3.9 ± 1.0 L/min· m, p<.001), stroke index (from 32 ± 8 to 37 ± 9 ml/m, p<.001) and oxygen transport (from 410 ± 105 to 530 ± 146 ml/min· m, p<.002). Oxygen consumption (VO2) increased concurrently (from 137 ± 42 to 162 ± 66 ml/min·.m2, p<.002). MAP increased (from 68 ± 9 to 76 ± 11 mm Hg) in 12 patients and decreased moderately (from 76 ± 18 to 69 ± 17 mm Hg) in six patients. The two subgroups of patients had similar hemodynamic profiles before the dobutamine infusion, but vasopressor therapy was already used in one of the 12 patients in the first subgroup and in three of the six patients in the second subgroup (p<.05). Tne BP decrease in the second subgroup was related to a vascular effect associated with a larger decrease in systemic vascular resistance (−24% vs. −10% in the other patients). A significant decrease in right atrial pressare (from 13.0 ± 4.2 to 10.0 ± 3.8 mm Hg, p<.01) also suggested a decrease in preload, Hence, dobutamine infusion at a dose of 5 μg/kg· min can markedly increase oxgyen supply and VO2 in septic shock, and is well tolerated. (Grit Care Med 1990; 18:689)]]></description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Cardiotonic agents</subject><subject>Cardiovascular system</subject><subject>Dobutamine - administration & dosage</subject><subject>Dobutamine - therapeutic use</subject><subject>Drug Evaluation</subject><subject>Female</subject><subject>Hemodynamics - drug effects</subject><subject>Humans</subject><subject>Infusions, Intravenous</subject><subject>Lactates - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Oxygen Consumption</subject><subject>Pharmacology. Drug treatments</subject><subject>Prospective Studies</subject><subject>Respiration, Artificial</subject><subject>Shock, Septic - drug therapy</subject><subject>Shock, Septic - physiopathology</subject><issn>0090-3493</issn><issn>1530-0293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkctOGzEUhq2KKoS0j1DJG9gN2ON7dwgKpYrUTbu2PLZHMUzGwfYo6tvXuZCuUL05Ouf_z0WfAYAYXWOkxA2qj7SUN1gphETNml0JfwBzzEhNWkXOwBwhhRpCFTkHFzk_VwNlgszArCWcCiTn4Md97KZi1mH00LgaQi7JlBBHGEaY_aYEC_Mq2pev8Na5sFdKhAbmYkZnkoObFEu0cfgEPvZmyP7zMS7A74dvv-6-N8ufj093t8vGUsZx01NnO0YdltwS03FFVMskEwKJnnPSGtZZ4mXnGENM9FISJrGXirFeOussWYCrw9y6-HXyueh1yNYPgxl9nLIWSjIsMfqvEfOKjgpSjfJgtCnmnHyvNymsTfqjMdI73vqNtz7x3pdwbf1y3DF1a-9OjUfAVb886iZbM_TJjDbkf_MVkRTz3Qn04NvGofiUX4Zp65NeeTOUlX7vu8lfCS6WbA</recordid><startdate>199007</startdate><enddate>199007</enddate><creator>VINCENT, JEAN-LOUIS</creator><creator>ROMAL, ALAIN</creator><creator>KHN, ROBERT J</creator><general>Williams & Wilkins</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>199007</creationdate><title>Dobutamine administration in septic shock: Addition to a standard protocol</title><author>VINCENT, JEAN-LOUIS ; ROMAL, ALAIN ; KHN, ROBERT J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4561-f4dcb54d186c3ab693925857707f6632a5bc3e8bd55057f883581e8955f8dcdc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Cardiotonic agents</topic><topic>Cardiovascular system</topic><topic>Dobutamine - administration & dosage</topic><topic>Dobutamine - therapeutic use</topic><topic>Drug Evaluation</topic><topic>Female</topic><topic>Hemodynamics - drug effects</topic><topic>Humans</topic><topic>Infusions, Intravenous</topic><topic>Lactates - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Oxygen Consumption</topic><topic>Pharmacology. Drug treatments</topic><topic>Prospective Studies</topic><topic>Respiration, Artificial</topic><topic>Shock, Septic - drug therapy</topic><topic>Shock, Septic - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VINCENT, JEAN-LOUIS</creatorcontrib><creatorcontrib>ROMAL, ALAIN</creatorcontrib><creatorcontrib>KHN, ROBERT J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VINCENT, JEAN-LOUIS</au><au>ROMAL, ALAIN</au><au>KHN, ROBERT J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dobutamine administration in septic shock: Addition to a standard protocol</atitle><jtitle>Critical care medicine</jtitle><addtitle>Crit Care Med</addtitle><date>1990-07</date><risdate>1990</risdate><volume>18</volume><issue>7</issue><spage>689</spage><epage>693</epage><pages>689-693</pages><issn>0090-3493</issn><eissn>1530-0293</eissn><coden>CCMDC7</coden><abstract><![CDATA[Dobutamine administration has been shown to increase oxygen delivery in various conditions, but there are little,data to document its effects in septic shock. We investigated the effects of dobutamine infusion at a rate of 5 μg/kg· min in 18 patients (mean 60 ± 16 yr) with septic shock initially characterized by hypotension, oliguria, and hyperlactatemia in the presence of a documented source of sepsis. Early resuscitation had consisted of fluid administration and vasopressors when required. When added to this standard regimen, dobutamine had no significant effect on mean arterial pressure (MAP) (from 71 ± 12 to 73 ± 13 mm Hg), but markedly increased cardiac index (from 3.0 ± 0.7 to 3.9 ± 1.0 L/min· m, p<.001), stroke index (from 32 ± 8 to 37 ± 9 ml/m, p<.001) and oxygen transport (from 410 ± 105 to 530 ± 146 ml/min· m, p<.002). Oxygen consumption (VO2) increased concurrently (from 137 ± 42 to 162 ± 66 ml/min·.m2, p<.002). MAP increased (from 68 ± 9 to 76 ± 11 mm Hg) in 12 patients and decreased moderately (from 76 ± 18 to 69 ± 17 mm Hg) in six patients. The two subgroups of patients had similar hemodynamic profiles before the dobutamine infusion, but vasopressor therapy was already used in one of the 12 patients in the first subgroup and in three of the six patients in the second subgroup (p<.05). Tne BP decrease in the second subgroup was related to a vascular effect associated with a larger decrease in systemic vascular resistance (−24% vs. −10% in the other patients). A significant decrease in right atrial pressare (from 13.0 ± 4.2 to 10.0 ± 3.8 mm Hg, p<.01) also suggested a decrease in preload, Hence, dobutamine infusion at a dose of 5 μg/kg· min can markedly increase oxgyen supply and VO2 in septic shock, and is well tolerated. (Grit Care Med 1990; 18:689)]]></abstract><cop>Hagerstown, MD</cop><pub>Williams & Wilkins</pub><pmid>2364708</pmid><doi>10.1097/00003246-199007000-00001</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0090-3493 |
| ispartof | Critical care medicine, 1990-07, Vol.18 (7), p.689-693 |
| issn | 0090-3493 1530-0293 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_79851810 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Adult Aged Aged, 80 and over Biological and medical sciences Cardiotonic agents Cardiovascular system Dobutamine - administration & dosage Dobutamine - therapeutic use Drug Evaluation Female Hemodynamics - drug effects Humans Infusions, Intravenous Lactates - blood Male Medical sciences Middle Aged Oxygen Consumption Pharmacology. Drug treatments Prospective Studies Respiration, Artificial Shock, Septic - drug therapy Shock, Septic - physiopathology |
| title | Dobutamine administration in septic shock: Addition to a standard protocol |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T02%3A52%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dobutamine%20administration%20in%20septic%20shock:%20Addition%20to%20a%20standard%20protocol&rft.jtitle=Critical%20care%20medicine&rft.au=VINCENT,%20JEAN-LOUIS&rft.date=1990-07&rft.volume=18&rft.issue=7&rft.spage=689&rft.epage=693&rft.pages=689-693&rft.issn=0090-3493&rft.eissn=1530-0293&rft.coden=CCMDC7&rft_id=info:doi/10.1097/00003246-199007000-00001&rft_dat=%3Cproquest_cross%3E79851810%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16007473&rft_id=info:pmid/2364708&rfr_iscdi=true |